| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |